Learn more

CORNELL RES FOUNDATION INC

Overview
  • Total Patents
    3,441
  • GoodIP Patent Rank
    19,892
  • Filing trend
    0.0%
About

CORNELL RES FOUNDATION INC has a total of 3,441 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1937. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are HARVARD COLLEGE, CENTEON PHARMA GMBH and DEUTSCHES KREBSFORSCH.

Patent filings per year

Chart showing CORNELL RES FOUNDATION INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Barany Francis 105
#2 Szeto Hazel H 97
#3 Gonsalves Dennis 94
#4 Beer Steven V 83
#5 Crystal Ronald G 75
#6 Macdonald Noel C 73
#7 Webb Watt W 68
#8 Craighead Harold G 64
#9 Wei Zhong-Min 64
#10 Chu Chih-Chang 59

Latest patents

Publication Filing date Title
US2015322537A1 Delayed fruit deterioration allele in plants and methods of detection
US2015086536A1 Methods of Predicting Acute Rejection Outcomes
AU2014203126A1 Methods for reducing cd36 expression
US10636093B1 Structured finance securities option pricing architecture and process
US2014045260A1 Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
JP2013035865A Use of vascular endothelial growth factor receptor 1+ cell in treating and monitoring cancer and in screening for chemotherapeutic
WO2011163353A2 On-demand dual frequency laser sources for non-linear optical microscopy and micro-spectroscopy imaging systems
WO2011137189A1 System and methods for mapping and searching objects in multidimensional space
AU2011001V G.935 Malus domestica x Malus robusta
CN102762741A Fluid flow device containing nanotubes and method for cell trafficking using same
WO2010129578A1 E. coli lpfa antigen for prevention and treatment of infectious diseases
WO2010121066A2 Silica nanoparticles incorporating chemiluminescent and absorbing active molecules
WO2010121064A2 Improved fluorescent silica nanoparticles through silica densification
EP3495000A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value
AU5300P G.41 Malus domestica x robusta
US2011195854A1 Detecting and monitoring inflammatory neuropathy
CN102160188A Inorganic bulk multijunction materials and processes for preparing the same
US2010016654A1 Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus
CN102046810A Inhibition of angiognesis
WO2009124178A1 Method for prophylaxis or treatment of feline infectious peritonitis